Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Abken

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
British Journal of Cancer|September 11, 2003
An anti-MUC1-antibody-interleukin-2 fusion protein that activates resting NK cells to lysis of MUC1-positive tumour cellsC Heuser, M Ganser, A Hombach, et al.
The Journal of Investigative Dermatology|March 1, 1994
CD7-negative helper T cells accumulate in inflammatory skin lesionsM Moll, U Reinhold, S Kukel, et al.
Gene Therapy|August 6, 1999
A chimeric receptor that selectively targets membrane-bound carcinoembryonic antigen (mCEA) in the presence of soluble CEAA Hombach, D Koch, R Sircar, et al.
Gene Therapy|June 29, 2000
T cell activation by recombinant FcepsilonRI gamma-chain immune receptors: an extracellular spacer domain impairs antigen-dependent T cell activation but not antigen recognitionA Hombach, C Heuser, M Gerken, et al.
Journal of the American Academy of Dermatology|February 24, 2001
CD4(+)CD7(-) T cells compose the dominant T-cell clone in the peripheral blood of patients with Sézary syndromeG Rappl, J M Muche, H Abken, et al.
Cancer Research|March 31, 2001
T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysisA Hombach, D Sent, C Schneider, et al.
The Journal of Investigative Dermatology|February 13, 2001
Dermal fibroblasts sustain proliferation of activated T cells via membrane-bound interleukin-15 upon long-term stimulation with tumor necrosis factor-alphaG Rappl, A Kapsokefalou, C Heuser, et al.
Gastroenterology|October 10, 1997
T cell targeting of TAG72+ tumor cells by a chimeric receptor with antibody-like specificity for a carbohydrate epitopeA Hombach, C Heuser, R Sircar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 21, 2001
Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor moleculeA Hombach, A Wieczarkowiecz, T Marquardt, et al.
International Journal of Molecular Medicine|December 17, 1998
Chimeric anti-TAG72 receptors with immunoglobulin constant Fc domains and gamma or zeta signalling chainsA Hombach, R Sircar, C Heuser, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
British Journal of Cancer|September 11, 2003
An anti-MUC1-antibody-interleukin-2 fusion protein that activates resting NK cells to lysis of MUC1-positive tumour cellsC Heuser, M Ganser, A Hombach, et al.
The Journal of Investigative Dermatology|March 1, 1994
CD7-negative helper T cells accumulate in inflammatory skin lesionsM Moll, U Reinhold, S Kukel, et al.
Gene Therapy|August 6, 1999
A chimeric receptor that selectively targets membrane-bound carcinoembryonic antigen (mCEA) in the presence of soluble CEAA Hombach, D Koch, R Sircar, et al.
Gene Therapy|June 29, 2000
T cell activation by recombinant FcepsilonRI gamma-chain immune receptors: an extracellular spacer domain impairs antigen-dependent T cell activation but not antigen recognitionA Hombach, C Heuser, M Gerken, et al.
Journal of the American Academy of Dermatology|February 24, 2001
CD4(+)CD7(-) T cells compose the dominant T-cell clone in the peripheral blood of patients with Sézary syndromeG Rappl, J M Muche, H Abken, et al.
Cancer Research|March 31, 2001
T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysisA Hombach, D Sent, C Schneider, et al.
The Journal of Investigative Dermatology|February 13, 2001
Dermal fibroblasts sustain proliferation of activated T cells via membrane-bound interleukin-15 upon long-term stimulation with tumor necrosis factor-alphaG Rappl, A Kapsokefalou, C Heuser, et al.
Gastroenterology|October 10, 1997
T cell targeting of TAG72+ tumor cells by a chimeric receptor with antibody-like specificity for a carbohydrate epitopeA Hombach, C Heuser, R Sircar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 21, 2001
Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor moleculeA Hombach, A Wieczarkowiecz, T Marquardt, et al.
International Journal of Molecular Medicine|December 17, 1998
Chimeric anti-TAG72 receptors with immunoglobulin constant Fc domains and gamma or zeta signalling chainsA Hombach, R Sircar, C Heuser, et al.
Pageof 7